Jamshedpur: Meherbai Tata Memorial Hospital to get 4-bed ICU on December 22
"We would also start Lutetium therapy at MTMH by this year-end for prostate cancer patients who have not responded to conventional treatment. This would be the first such facility in the state of Jharkhand," said Dr Mitra.;
Jamshedpur: Expanding its wings, Meherbai Tata Memorial Hospital (MTMH) will launch a new 4-bed Intensive Care Unit (ICU) on December 22, announcing that new facilities will also be added to cater to the needs of cancer patients.
The hospital will start Lutetium therapy — the first kind ever in the state. Lutetium-177 vipivotide tetraxetan PSMA therapy (Pluvicto) is a new theranostic medicine for advanced metastatic prostate cancer. It's a type of radiation that specifically targets a molecule on the surface of prostate cancer cells called PSMA.
A new MRI machine will be installed at the Tata Main Hospital campus for the convenience of the patients. To protect blood cancer patients from any infection, the hospital has recently established three specialised cabins for their safety.
Also read- Tata Memorial Centre, Vedanta BALCO Medical Centre Collaborate For Cancer Care
A state-of-the-art TrueBeam radiotherapy machine has been installed at MTMH which is a medical linear accelerator developed by Varian Medical Systems. It provides image-guided stereotactic radiosurgery and radiotherapy with high precision to treat tumours and lesions in various parts of the body, including the lungs, breasts, head, and neck.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.